Hostname: page-component-7c8c6479df-xxrs7 Total loading time: 0 Render date: 2024-03-27T02:09:24.106Z Has data issue: false hasContentIssue false

Serological evidence of Bartonella spp. infection in the UK

Published online by Cambridge University Press:  01 October 1999

T. G. HARRISON
Affiliation:
Respiratory and Systemic Infection Laboratory (RSIL), PHLS Central Public Health Laboratory, Colindale, London NW9 5HT, UK
N. DOSHI
Affiliation:
Respiratory and Systemic Infection Laboratory (RSIL), PHLS Central Public Health Laboratory, Colindale, London NW9 5HT, UK
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

We reviewed serological and epidemiological data relating to 1000 consecutive patients from whom specimens were submitted for estimation of bartonella antibodies, using MRL Diagnostics Bartonella IFA IgM and IgG kits. Using 289 control sera, we estimated the specificity of the kits as [ges ]99·0%. Evidence of bartonella infection was found in 16·3% of patients examined. Rates varied by patient group: 20% of patients for whom a diagnosis of cat scratch disease (CSD) was considered probable had evidence of infection, as did 10·4% of patients with ‘possible CSD’, 8·1% of patients with possible bacillary angiomatosis, 18·2% of patients with ‘culture negative’ endocarditis and 17·6% of patients with possible bartonellosis with ophthalmic involvement. An IgM response was seen in 6·6% of patients and IgG in 15·1%. Cases were more frequent among males than females (18·5% vs. 13·9%). Analysis by age showed that although rates of infection were highest in the decades 0–9 years (19·4%) and 10–19 years (20·7%), they fell only slightly in the next three decades. MRL bartonella kits appears to provide a useful and specific approach to the diagnosis of these infections.

Type
Research Article
Copyright
© 1999 Cambridge University Press